RNA Therapeutics Market Research Report 2023: Focus on mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides - Global Forecast to 2028
January 31, 2024 05:59 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "RNA Therapeutics Market by Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides), Indication (Infectious...
Transfection Reagents and Equipment Global Market Report 2024: Market Set to Soar with Emerging Trends and Growing Healthcare Expenditures - Long-term Forecasts to 2028 and 2033
January 25, 2024 09:32 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Transfection Reagents and Equipment Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global market for...
Global Oligonucleotide Synthesis Market Analysis and Opportunity Forecast 2023-2028 - RNA-based Therapeutics Show Promise, Boosting Demand for Tailored Oligonucleotides
January 10, 2024 11:23 ET
|
Research and Markets
Dublin, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The "Global Oligonucleotide Synthesis Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ...
Ractigen Therapeutics Advances into Clinical Stage with Groundbreaking saRNA Drug, RAG-01
December 06, 2023 07:00 ET
|
Ractigen Therapeutics
This milestone marks Ractigen's transition into clinical development, with RAG-01 targeting NMIBC.
Global Gene Therapy Research Report 2023-2028: Increasing Regulatory Approvals, Growing Investments, Rising Demand for Cell & Gene Therapies
November 17, 2023 09:13 ET
|
Research and Markets
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy Market by Type (Gene silencing, Gene augmentation), Vector (Viral (Retroviral, AAV), Non-viral (Oligonucleotide)), Therapeutic Area...
Ractigen Presents Preclinical Results of Its saRNA Therapeutic Targeting DMD/BMD at the Oligonucleotide Therapeutics Society (OTS) Annual Meeting
November 02, 2023 08:00 ET
|
Ractigen Therapeutics
Ractigen Presents Preclinical Results of Its saRNA Therapeutic Targeting DMD/BMD at the Oligonucleotide Therapeutics Society (OTS) Annual Meeting
Global Gene Therapy Market Poised for Remarkable 9.26% CAGR, Expected to Reach USD 10.13 Billion by 2028
October 31, 2023 08:48 ET
|
Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's...
DNA Encoded Library Market Set to Reach $840 Million in 2023, Driven by Transformative Impact on Drug Discovery
October 17, 2023 07:53 ET
|
Research and Markets
Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The "DNA Encoded Library: Platforms and Services Market (2nd Edition), 2023-2035" report has been added to ResearchAndMarkets.com's offering. The global...
Advancing Beyond Antibody Drug Conjugates: Next Generation Drug Conjugates Emerge as Clinical Efficacy and Stability Game Changers
October 12, 2023 05:38 ET
|
Research and Markets
Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The "Next Generation Drug Conjugates Market: Distribution by Type of Targeting Ligand, Type of Payload, Type of Therapy, Route of Administration, Target...
Global Oligonucleotide Synthesis Markets Research Report 2023 With Executive and Consultant Guides & Forecasts to 20277
October 05, 2023 06:38 ET
|
Research and Markets
Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides. 2023 to 2027" report...